Treatment of ANCA-associated vasculitis

Pharmacology, Toxicology and Pharmaceutical Science

• Vasculitis 100%
• Autoantibody 100%
• Wegener Granulomatosis 60%
• Remission 60%
• Immunosuppressive Agent 20%
• Disease Severity 20%
• Randomized Controlled Trial 20%
• Disease Activity 20%
• Clinical Feature 20%
• Small Vessel Vasculitis 20%

Medicine and Dentistry

• Vasculitis 100%
• Granulomatosis with Polyangiitis 60%
• Randomized Controlled Trial 20%
• Clinical Feature 20%
• Microscopic Polyangiitis 20%
• Immunosuppressive Treatment 20%
• Spontaneous Remission 20%
• Disease Activity 20%
• Hand-Schüller-Christian Disease 20%

Immunology and Microbiology

• Autoantibody 100%
• Vasculitis 100%
• Granulomatosis with Polyangiitis 60%
• Immunosuppressive Therapy 20%